Company intelligence / Profile preview
Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd.
- Ownership
- Private
- Development stage
- Phase 2
Overview
Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd. is a leading Chinese pharmaceutical company focused on research, development, manufacturing and commercialization of innovative medicines targeting oncology, cardiovascular diseases and metabolic disorders. The company leverages advanced technologies to address unmet medical needs domestically and internationally. Its pipeline includes both small molecule drugs and monoclonal antibodies with programs spanning early clinical to approved stages.
- Therapeutic areas
- OncologyCardiovascularMetabolic Disorders
- Modalities
- Small moleculesMonoclonal antibodies
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd..